Probiotics as a therapeutic strategy in Major Depressive Disorder
Introduction Major depressive disorder is a prevalent disease, in which one third of sufferers do not respond to antidepressants. Disturbance in the equilibrium of the gut microbiota has been involved in the pathophysiology of depression. Probiotics have the potential to be well-tolerated and cost-...
Main Author: | L. Vargas |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2022-06-01
|
Series: | European Psychiatry |
Subjects: | |
Online Access: | https://www.cambridge.org/core/product/identifier/S0924933822014201/type/journal_article |
Similar Items
-
Are probiotics beneficial for obese patients with major depressive disorder? Opinion for future implications and strategies
by: Theresia M. D. Kaunang, et al.
Published: (2023-05-01) -
Exploring the Role and Potential of Probiotics in the Field of Mental Health: Major Depressive Disorder
by: Dinyadarshini Johnson, et al.
Published: (2021-05-01) -
Microbiota-Induced Epigenetic Alterations in Depressive Disorders Are Targets for Nutritional and Probiotic Therapies
by: Shabnam Nohesara, et al.
Published: (2023-12-01) -
A Microbial-Based Approach to Mental Health: The Potential of Probiotics in the Treatment of Depression
by: Dinyadarshini Johnson, et al.
Published: (2023-03-01) -
Psychophysiological Effects of <i>Lactobacillus plantarum</i> PS128 in Patients with Major Depressive Disorder: A Preliminary 8-Week Open Trial
by: Hui-Mei Chen, et al.
Published: (2021-10-01)